Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Krul ES, et al. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. J. Clin. Invest. 75: 361-369, 1985. PubMed: 3973009
Hahm KS, et al. Limited proteolysis selectively destroys epitopes on apolipoprotein B in low density lipoproteins. J. Lipid Res. 24: 877-885, 1983. PubMed: 6195279
Krul ES, et al. Regional specificities of monoclonal anti-human apolipoprotein B antibodies. J. Lipid Res. 29: 937-947, 1988. PubMed: 2457642
Kinoshita M, et al. Modification of the core lipids of low density lipoproteins produces selective alterations in the expression of apoB-100 epitopes. J. Lipid Res. 31: 701-708, 1990. PubMed: 1693649
Tikkanen MJ, et al. Expression of apolipoprotein B epitopes in very low density lipoprotein subfractions. Studies with monoclonal antibodies. Arteriosclerosis 4: 138-146, 1984. PubMed: 6200098
Krul ES, et al. Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis 9: 856-868, 1989. PubMed: 2574033
Tikkanen NJ, et al. Antigenic mapping of human low density lipoprotein with monoclonal antibodies. J. Lipid Res. 23: 1032-1038, 1982. PubMed: 6183385
Tikkanen MJ, et al. Differential reactivity of human low density lipoproteins with monoclonal antibodies. J. Lipid Res. 24: 1494-1499, 1983. PubMed: 6197500
Krul ES, et al. Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. J. Lipid Res. 29: 1309-1325, 1988. PubMed: 2466929
